SCHEMBL7511027

SCHEMBL7511027

Clc1ccc(Cc2ncnc3ccccc23)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.57
HTT P42858 5/20 0.55
PDE4A P27815 1/20 0.50
PDE4B Q07343 1/20 0.50
PDE4C Q08493 1/20 0.50
PDE4D Q08499 1/20 0.50
LMNA P02545 2/20 0.48
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46
KMT2A Q03164 1/20 0.46
MAPK1 P28482 2/20 0.44
MAPT P10636 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ACHE P22303 1/20 0.42
PI4KA P42356 1/20 0.42
PI4K2B Q8TCG2 1/20 0.42
PI4K2A Q9BTU6 1/20 0.42
PI4KB Q9UBF8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1108399 0.86 EGFR (0.53) EGFRHTTPDE4APDE4BPDE4C
SCHEMBL8545576 0.84 HTT (0.59) EGFRHTTPDE4APDE4BPDE4C
SCHEMBL7516533 0.80 EGFR (0.60) EGFRHTTLMNARAB9ASMN1; SMN2
SCHEMBL27887765 0.78 CCNC (0.43) EGFRHTTPDE4APDE4BPDE4C
SCHEMBL7511726 0.77 PDE4A (0.50) EGFRHTTPDE4APDE4BPDE4C
SCHEMBL28174588 0.75 KMT2A (0.58) LMNASMN1; SMN2KMT2AMAPK1MAPT
SCHEMBL1446555 0.73 LMNA (0.48) EGFRLMNAMAPK1MAPTL3MBTL1
SCHEMBL9921507 0.73 EGFR (1.00) EGFRHTTLMNARAB9ASMN1; SMN2
SCHEMBL12603256 0.73 AHR (0.50) EGFRHTTLMNARAB9ASMN1; SMN2
SCHEMBL7513679 0.73 APP (0.60) PDE4APDE4BPDE4CPDE4DLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832073-B1 QUINAZOLINES AND PHARMACEUTICAL COMPOSITIONS SUGEN INC (US) 2002-01-16 EP claimed
EP-0832073-B1 QUINAZOLINES AND PHARMACEUTICAL COMPOSITIONS SUGEN INC (US) 2002-01-16 EP disclosed